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Chapter 7 
Summary and conclusions 
Summary 
first gc1;xl 0.5 this chesis was to  investigate the potential cardioprotectlve effects af 
rlie anmcrxidant 7-monohydroxyethy1i~ltc)~idc (moncrWER) in an 2r1 PZUO mouse model 
of cardiac ischaen~ia-reperfurn ('LR). T11c second goal was to determine the early 
alterauom In caudiac pb-otein expression In this IR model in order t o  clehneate the 
mccl~anisms of action of monol-IliR rn this setting. 
As the m ~,v)~o mouse motlcl of cardlac UlZ was the study object of this thesis wr 
compared an chapter 2 the long-term stmctl-~ral and f~~nct ional  conseclucnces of  thts 
myocardial infarction made1 to rhe ones ~ndurcd  by permanent ischaema (PI). 
'i41i1. ~-n:ij~iriry of studies on cardlac HR injury hawe focused on the slmrt-term 
consequences, of reperfirsion. Using niyocardial rnfarct s u e  or neutropl-dil irlfleix ns 
paualzieters, rhc ~-vrogrcssnor1 tsf cardlac tissue damage has been described hz the time 
frame of $1 Fcu hours LIP to one or  a few days after the initiat~r~n of reperfusion. The 
long-~erm effects of 1R injury, in terms of weeks nr months, arc less well examined In 
t h ~ s  i17 f,rt,u tmou9e nnodel. T'hls is, hc>u*ever, a relevant aspect for extrapolation to thc 
clrnical seitlng as 11 may be rliar [he outcurne of intelnrenl~inns that are brneficral 
shortl! after ininarion of ~repesfus~on is different: u.hen the eval~~at lon talies place at 
later hmges. 
In chapter 2 wc showed tlaar the long-tern1 strucrusal and funccronal consequences 
following caccliac 1R arc cllfierer~t- from those abse~u-cd a f ~ e r  PI. Contractillq of the 
heart was c'lepresscd for at Pcast 2 \t:eeks after lR, but was ~iearlj, restored after 8 uieclis 
of 1R. i l f ~ c s  cartll.;lc IR, the gross ascl~itecturc uf the ventricular wall was preserved 
an11 r l ~ e  wountil I~e~lirug process \mas charactenzed by cstenslr-e calclficauon, minor 
layperrtsphj. and tlxnor dllatadon. In the PI model, die ischaeni~lc area was not 
calafietl, b~ifi completely rcplaced by ct>linectlve ussue. 111 addition, the rrentracular \iiall 
was severely dilatecl,   he rcrnainlng rnyocard~al ~i~cnscle was strongly l~ypertropl?iccl and 
loss of c>~rtUiac E~~nctiol-i was permanent. 
'T11e: paienu:ul protecrnre effects o r  L ' S O ~ ~ ~ T ) L P S ~ ~  ~ (~J ~n i t i i s t~ r ed  a ~ ~ t i o x ~ d m t s  017 card111~ 
~"cl~erftrslr~ll 1111ur\ II:~QC been studied csrensi~cly, I-lowever, 21s descr~lred rn dceail i n  
clraptcr 1, tlre I>rnefict:zl effccrs r ~ f  ,nnaio~~clnirt imatmcnt En 11iese rnoclcls rcnaain 
ccsntro\crszal ,rnd rlccd turthcr clanficntio~i. hdoreo\~er, most ol' rllcsc studies cmly 
rn\*t.\l~g,rted potcnti:i2 sli i)~.r-tcfr~~~ protectxrc cfkcts after ~ninaricrn of rcperfi~stc,n anci 
did 11oi osil11llnc srlst:l~rzcd protecl-ivc effects. 
In chapter 3, wc ci.:lluatcd the c:trdloprntectl-\ic et'fecrs of tlic anuoxidant flrrzionoid 
mcotrr~l-lE<R un ~ l i c  r/J ris:a rnousc rncjdel (4f carci~ac 11% LIP till ~ v o  weeks after IR, a tune 
1301111 wllcn w*o~~rrd  l~enlit-tg IxcJcesses arc complcrrd. '~Phcrc were three intlicatltrns that 
rnonol-11% 1111ght 3ct prx)scct~\-c agalnsr inj~ury In this n~odcl .  Tlicse were: I / sarong 
raclicd ~ C : I \ . C I I ~ I O I ~  :111d 1 0 1 1  claclah~ig ]-*ropetries of rnonotlI33; 2 J proven prorectlvc 
effecrs of 111nt1tsl 11R agaunst: c i o ~ o r u b ~ ~ i ~ i - l ~ ~ c l ~ i c c d  careliotowc~t?r ~ I I  1,islo in mice; 3 J /a  
I Y ~ Q  ~ I I T I - Y ~ I ~ ~ : I I ~ I I I I . I I C > ~ >  eikcrs of  rnc~no1-lliK by recluc~ng ncutruphil adhesion. 
We shocc-crt 1118~ ~~ic>notlI<R cxerreol a sust:uned cardioprotecriwc cffccr in chis rilirf~u 
Iiaouse r~iodel of cardiac 1R. '7'111s n.as denrotis~rnred at mitr time pc~n t s  (24 hours anci 
2 ~veeks after IR) by the hcr  that naonoHEW signific3ntJv ee~ltrcerl rn\.iic:ir~i~nl 
neutrophll influx, infarct a7e and masnienancc of cardiac conanct~le respcmscs tvYzen 
the lieam was stressed with dobutamlne and volume lcdaci~ng. 
To our knoadedge, this nras the first time that susl;imec! protectlac effects (in rrrms of 
weeks) of a fiavoncrid are demonstrated ln h i s  cardiac 1R model. 
Thae uming, route and dose of rncmol-IEIt adnn~rzistrarion. in this study (clz,~prer 3) 
based on earlier i~n FTVQ mouse studies in 1a.hic1~ tnon~>'I-.IliR protec~ed ngalr-isr 
doxorub~cin-induced carciloromcity [I, 21. 111 these st udles ~~lrranukl l :K ~ f u s  
aclmtmsterecl inwaperitaneally one 11our before dosol-wbic~n ~lljcctlon~. 
C h i  rously, to mininl~ze rnpocarr~rzd damage evuked by chemotherapeuac ngrc-nas such 
as doxorubrcin it is Iogicai t o  pre-treat patlezxus wit12 radical scnvenging agents such 11s 
rnonoHEl<. I-Iowc~er, \vl~en prcl~et~nng "reperf~lslon ~njury"+~rndl~~inistering at1 
antioxidant as a protecdve drug before tl-ne onset of ischselzlln, bas less clinic;~l 
relevance. In a d d i ~ a n ,  recent pharmacokineuc data in 1mlce re\realed that fr1klcnv1r7g 
Intraxrenous injection of monoh-IER maximal ~i~yc~cardial nssuc concentmadons al-' the 
clrug \\-ere reached almost in~nvediately (3.1. 
Therefore, in chapter 4 we set out 3 s t ~ d \ l  rr) test if ~IIC~UIO~-~I<R \-1'0uld also 13c 
eCfective nrhcrv aclministered intravenously five I I I ~ P ~ U I C S  I E C ~ O T C  rcpcrf~usuon. 
s'lclmin~str-awn of monoF1GR at tl~ts lime pomt neither fiffecrcd rlie influx crf 
nel-atrophils IJJ, the injured ussue nor improt-ed st i r~ula~cd carc_l\;~c ontractility, 24 
hours after reperhasion. 
Thus 1monoH1" ppd-otccts la an b c i ~ o  mo~ise moc'leY of c~rc11ac 1hZ M ' I ~ U I I  i~Jrn~ni.steretl 
intsaperisoncally one hour before ischacm~a bur Iachs tbesr 13ropc~lics \vhen npplred 
intravencrr~rsly five minutes before repertils~on. 
T h ~ s  discrepancy in res~llts @enveen chapter 3 and 4) indlca~eh that tlvc trmc [301nt of 
monoHER adrninustl-a.tion is ipen crucial to obtain card~oprorcrtlve uf'Eocrs. 
Among the explanatlnr~s for the lack of a clear pl-n:~rrnacoel~~nam~c effe t 06 rnor1ol-1IIR 
in the latrer study (chapter 4) are: I )  the portct~aual restricuon in ti~!ocard~al ealt3takr: o f  
naunoHf<R in conditions of cartirac I l l ;  2) tl-nc nccesslt? of fC31.KIi11113~1 of :IcU\ L' 
merabol~ies of mono14lf:li; :~nd 3) the posstbl l~t~ that card~r)l>z+o~ucl~c efictq arc, 
dlrecrlr (4r oficn~qse indlrcctly via antioxltlant- cffccls, ~ L I C  1 0  I I I ~ ~ T ~ C I ' C I I C C "  ot.
I ~ ~ ~ I ~ ~ H I ~ R  with spcclfic signal sransductro~~ sntlva~aj*s d~1r111g 117c I S C ~ ~ C ~ " I Z J C  perlocf. 
Such srgnal rransductjon patliwa~i.; might bc asqociatcci ro rhc pt-orcctiwc rncckraniisnl of 
a c ~ i ~ n  of mt3ntJL31~',li. '4s s1~rla1Eng pathu:a!ts constsl nf pi-nru~ns, i t  is c<ser.lt~aI to s l ~ ~ r l ) ,  
chAnges ill proccln expre$sic,n crl- l.m~r-fransl~i~cmal rnodbfic:r~lon.; or I7j(jlci!1$ 1 0  \ ~ ~ r l f ! '  
this d ~ y ~ p r ~ r h ~ s ~ s .  
To scarcll for illohe, l u r O  S C L ~  of ~ ~ I L ~ C O I S I ~ C  \ICLCLICS \\cre perfurnred In u,h~ch u-c ~ 1 5 c ~ 1  a 
rechmique of 2-U3E cornb~ned u ~ ~ r h  mass xpccTrot~.settl)' (MS). \We s~uclrr-d c..~rlj (2 I0 
mrn) changes in prtrteln expression because wc were pr~un:lrily ~~ltcrcrtccl in rinclrt-ig rhc. 
reason for the prnLecuve effccts of rno~~r~l-ll>lt. I11 acld~tion we xvcre ~ntcrcstcd 111 
~denr l fy~ i~g  po ten~a l  new targets for ~arcl~oprotect~on tlqa1 arc bencficaal Irr ~hc first  lev,. 
~ C ) L L ~ S  of ~ E ~ C I C B T ~ T ~ ~  infarction. Prcvlous s~uclles showed h a t  b j  ~lslng ~111% tcchnlquc 
o f  2-131: and MS lr  1s possjble uj detect early ;dteraoo~rs m the proteornc induced by 
cardiac 1R 14-61. 
In chapter 5 wc compared proteln d e n s q  changes rn the area at r ~ s k  of the mouse 
heart fr,llowing oss w ~ o  PI 2nd BR. Wc analyzed cyroscolic as well as membrane fracnorrs 
and found :I total of thirty-rwu protein spots (out of about 66313 matched spots) &at 
were dlffercntiaUY cxpressecl. Wirh this technique we were able to find menqr protei~?i 
spors rhat were changed In cupref;sioal level after PI alone, four protern spots that were 
c l ~ a n ~ c d  in expresson l e t ~ l  atier LR alone, and clght spots that cl-ranged commonlj In 
both models. '$he rrsultc of  this stud1 are herefore a source for further st~ldles in 
wli~cli the specific t~uiictional rclcrancc of tliese Isrotems In models of rnyocardlal 
inihrcat~n can be ~nvestnga~cd 
Idca-nuficd prrvtcins (by &""*IS) could be classified mn seven funcrlonal groups being t l ~ c  1 / 
anticc~agulanl- prorerns (Annexln A3 and ilnnexin A5), 2/ strucmral proteins (cardlac 
tropanio T', a-~ropornjrosin and a-myosin heavy cham), 3/ mflammaroq-relatecl 
proteins (serun? alnlylloid I?-component precursor), 4/ tral~scrtption- and rranslaixon- 
relatecl protclns (PL.O~BLDI~III : nd tlisti~Gnc T r ~ a d  Nwcleotidi- Binchng Protell1 1, 
I-fercrogcncous Nuclear Ribon~rcleoprote~n I<), 51 hear shock proteins (IIeat Shock 
Prorein 2[3&27), 6 /  t-r~etabol~sni-relarcd proteins (Adenylate l i~nase  1, Pvruvare 
lIcl~lrdrogcn:~se l Colnponent l3cta Subunlz, Catechol-0-Methjlltra~isfcras~ and 7 / 
mrsce1l;intst~us (dual specificlr) pllosphatase, s~milav to Zn-alcol~col clehyclrogenase). 
A remarkablc firuchng uias the 1R spcc~fic translocauon of anncxins (A3 anid A.5) fri~1-n 
thc cvtosol~c to the n~cmbr:ulc co~npartmenl, a pl.nenomcncrn tl-rnt was verified bj 
Western blorting. The fact that tl-ris lahenomenon occurred after reperfusion only and 
nor aftcr permanent ~schaernln su<gests a specific related mechanism that urggcrs 
tr:111~10cnt~oi1 of at1ticxi11s to ihc mernbrane fraction dulrlng rcpcrfuslon. 'These 
f ndlngs may gnre new irpiperus for fiirtlier szudies in relation 10 mnextns and early 
d~agnos~s  of repcriirsion injury in ctlnnection u71th earher studies frfi-orn our laborator! 
171. 
For~r  promois were changed an expressloll level a t  rnuilu~>le spot locatic,~~s, 
cl~arizc~crlnecl 11 d~ffcrvtice in ~soclecrr!c po~llt .  I n  chc case of cardlac trolsonlrz T ancl 
I-IS1'-20, tllcsc ch.1ngc.s wlcrc ,~ l so  clepcndent iln the tmodel. In ~ddmhon, one spot for 
tlic jj>r.tjreln\ ;~c'lcnyl;~le I \ I I I ; I S ~  1, cardlac trtrpo~aln 'r ,lncI f ISP-21) 'ia~as un~quelt p r c w n ~  
~n rhc I13 :rncl/or PL m11-1 not In 111c rcs~-~eccr\.e dxlm groups. 1:urthcr resc~;rrch 4r 
I ~ U C C * S E I ~ \ ~  to C ~ C ~ I ~ I L L I C  the ch;~rac~er of possable p~tholog) reil:uted post- l ransl :~uo~~d 
t n o c ~ ~ l i c a ~ ~ o ~ i ~  
i\ I O I A I  c ~ t '  ~\lrcl l~c protein b p o t ~  clranged sign~ticantly rn expression levcl a fx r  caa-di:rc 
113 (cl~apter 6). 'l'czr t r u  these I-rratcrn s p o ~ s  coulcll be characterizvd I>\ MS. These were: 
I-lc;~r Shock Pt.oietn-20 2nd Hear Shock Protein 27, t1eresogenrc~u~ Nuclear 
Ribi~nuclcoprotrinn IT, P y ~ ~ r v : ~ r e  13cliydroge11lzsc L;,l-P, t'lnnesln A3 (at 2 spot 
locn~lons), BILP~B Spcc~ficnt!. PIiosp11alase-3, Carechol-IQ_4-hIetI1~~Itra11sfc1'dse, and 
rldcn).l:tte I<in,~sc 1 (a1 3 s p o ~  Ic~canorls). 
I nt~aperrtone:~l a c~m~n l s t~amm o f  monol-lER, onc hour before ~scl.raemin, clid not altcr 
1111s protcu1 expressi~n profile related to card~ac IR. T h ~ s  tneans that the proven 
c:lrdroprotcr~~rre ffects c)f n ~ o n u [ i l ~ R  as, evldcnced at '1 later time polnt on 
hisroiog~cal and funcoonal lcvd were not detected on pmtromc 1c~~c.I at in cariy nnic 
point by usng the current teclumques. 
The discrepancy between these nvo studies in chaptrrs 3 m ~ d  6 niay I x  espl:liricd by 
due possibhty: I /  that monoHER did not affect changes ln protein esl,rcssiotl after 
cardlac 1R; 2/ this  trme point was nor relevant to detect d e r a a n n s  caused by 
rnuniaHER; 3J  the tecl~mque \are used in diis study may nor have been able to detect 
alterations zrr the proteloirnc specificall! tr-lgcred by monoH1;R. 
Concilusions and implicatians 
Thp ~Eisct*@ung i;tl otttcwne svzth r~nt io .~~dat~t  ts-ed~t~~t~nt rel'trts' to inrdSnl lli 
-As summarlzed m tlne general introdwcriolr to  this thesis. nu t~~c rous  r,l t>itri~la arlct ~ I I  tliiicl 
srudles have exalrrincd tlue role of alztiorldanr en;.ymrs a~lcl less spcafic anuc~~id:nnt 
izrte~~lentions In recl~acing carrlilac IR injury. Thc results of tl.re\e s r~~dres  -\.el-! 
ccrnfrlicung since t11e number of studies In which proaecrt.r-c effects were protQcn xnrrrs 
comparable to tlie rlumber that could tuot. Fun-~lierrnore, it rs reasonable to rzsslrrnc 
that nunzerous sn~cl~es have been performed, tliat dld tnol rcacli rhe stage of 
pubhcation, bccause protccrdve effccts of the anuuxldant urzcler 111vesug;ttion was 
disputable or  even could not be proven utldei- certdn ccrndirions. 
Although research on this ropvc started already m rbie car111 eighties, a clear explanatio~a 
f c ~  this discrepancy is, up to tio\qi, not linown. Among the espcrirnerltal v:~ri;llsles thar 
have been posti~lated to explarn these crrrrflictlng results arc: I /  animal specrcs; 2/ 
general features of the experiine~~tal model (e .8 a ~ l a e s t h c t ~ ~ e d  or  a\vrzke mc~tleP, opun- 
o r  closed- cluest model); 3/ tlue presence or absence of crntical stetlosis; 4/ diarar~on of 
ischaemia; 5/ duration of reperfus~on; 6/ phar~ziacoiii~~e~ic cansitlcrauons; 7/ 
methodology to infarct size; alzrl %/ inclusion o r  ot~iissir>n of sneasurelixctits 
to control for baseline predictors of Infarct slze (e.g. colla~eral bloo~l  flow). kloc\,erer, 
up to 11o\b-, there 1s no s~ucty available In Jiteratl~lre that veally proved that one of tllcse 
Factors o r  a comhin~arion of thcrn is the cause far this discrepancy. 
Studies ~ r a  transgerric tnaice \~liirl? altered Icvcls of alanioxidarrt crr~ymcs ctsnsictentlv ~ielcl  
results in support of a detrlli~ctlt:il t c~ l c  fix reirCtl\re r>uqpgcn spcc~c.\ (RC3S) ~n 
experitnenr:lJ miocardial 111 injut-)' (chapter I). 'l"lils tmcanx th:11 nhc 1:lcl.; of c f f ~ c l  of  
tlTese exogenous anohoxidants tm), bc (lri ~ : ~ r l )  due t i)  21 res~rictcd :ICCL'SS 1 0  tl"l CISIECS (>I' 
ROS genera.dol-P. As t1 . l~  capaclly of an  anocjx~ckmr to g u n  cncry ICJ lllr IHrgct & ~ V ~ L I C  
and ,--]rs ROS-pr~aduclrig intxxxllular cornpnrtl73c-nts o r  cites 15 at1 
inarportalxt condidon, tlzms abrliry nrreds to b e  \erificcl. 11 vrflll rrot bc C U T ~ I ' I S ~ I I ~  ~f 
rherapies Earl if rhcy do am[ succccsliully cnter rlicsc ccrunpax~ments. 
S ' S I ~ ~ ~ P ~ ~ ~ L ~ L O ~ E F J O , ~ ~ I  ~l ~ ~ G I ; J .  (ft~/zr potnr 01 ~ c / / I I P ~ ~  
In addjtion to t h s  explanation, our study W I ~ E ~  i-nonol-ll<li. rcvealcd r h a ~  r-12c tlnse ~ O I I T ~  
r r i  ad~n~~~lsl t r~ut ion of the anuc>xician~, t(1 act prrstccrlvr, ~iiighr Ilc vcsj crucial. 
Clllo~loI-IEK cncerled pr0tectl.r.c cffcc~s when I r  was adm~n~strr:~red one hour lxfore 
cardlac Ischaemla. In  contrast, nn @roiect~\,c) efkct  was fc~unc\ whet1 rt uras :ap-rp]rlccl 
inrle.i-enous]y right before reperfuston. This p h c n o ~ ~ ~ e o o n  113s Ixen olwervctl also i n  
the doxorublcjn mowsc model. hlrsnol-ll:R protected against h e  casolio~trxlcrty o r  
doxorublcin when it was adpmjnistered one hour before: doxosub~c~n veatmenc but nor 
wl-uen ~t was appl~rd fivc imnutrts before dexorublcrn eeatnlent (unpuhh%hed 
a~bscrvatlon, Pmf. Aalt Bast). The data suges t  that thrs ume-dependency may be a 
sg~rc~fic charactenstic of rnofroHliR. Srud~es with superoxide &smwt;isc 181 and a 
glutathronc ana1ogmc 191 nn dogs, as well as an a-tocopherol analogue in rars 11131 and 
melatonin, in inxe I 111 demonstrated that the time point of antioxidant adrrrinistratlon 
d1c3 nor influence the protective capacity of these antioa\ceclanrs in ~ I P  liisro models of 
expenment'x.1 cardiac IR. Pn d d l r ~ o n ,  studles in which the time poltlt of  adnnntstratl~n 
of the antioxidant was shown to bc crucial for its protccuve effect are not available m 
L~tcratwre. '1'111s means that t l ~ c  observatmtz that the efiicacy of a n t ~ o ~ d a n t  therapy is 
clepe~adctit tan the wrnc pcrlnt of admrnisoration i s  not a general concept. 17urthcr 
rcscarch as therefore necessary to dctermkne this specific mechanisrn of acuon of 
rnonoH1X. 
'The dlonxnant ccsnccpr of antloxrdant therapy during cardiac 1R 1s that the 
antroxidant agent reduccs the deuiniental effects of  oxidauve stress specrficdy durlng 
thc ~nlrral pilase of rcpcsfuslon by scavengmg ROS [9, 121. Recet~t phartlzacohneuc 
soudlrrs with 11101~oHliR showed that the peak concentration of rncmol-lEli in hear( 
tishue of ~azlco was reached almost nmmect~atcly after Intravenous admirustrauon 138. 
This iti~phes that also ira. our current cardlac IR model rhe hlghcst cardrac tissue levcls 
of ~iao1ioF113R, wlaei"iadmn~stereil intr~venuusly, r~glit before repcrfusaon, arc reached 
very car]? (w~tl~in o c minure) after the ~nltnaaion of reperfusion. 
Since d11s corresponds wlth the phase ~t wlalch the producrlonl of ROS is the lughest 
(9, 131, ~t \ir:ls very ~lnexpected that monoHB7R treatment lacked zny beneficial effects 
when aclm~n~srcrcd right befare ueperfuslon. At the nlomeslt ure do not have a clear 
explanat~on for ~ h ~ s .  rlnalyzlng rile pliarrnacohneucs of manol-113R specnficall! In our 
cardiac 1R model anci cleterminirrg the cnrrelaaon I~ehniieen cardiac ussue levels of 
mnrnmol-IER and RC3S during reperf~lston gives the: opportunity to tcst ~f the domlnant 
concept (sec above) apphcs for niol~otIEli  too. If thvs is not the case, a llog~c 
explanaunn t1i:ty be that rhe antlas~danit monol-IER protects agalnst deirirrrent:ll 
cffcc~b alurilag ahc pertoel of n~cha~1111.r ;~nd rror cluring tlie llnuhe~l phasc of reperfus~on. 
In rh~s c:m, n f  1% also ev~drnt that tljlerc arc doubts ~ I ~ O L I ~  the truth of tPxs do~iiinanl 
concept that ROS acc tlctnmcn~nl nlually aftcr rcperfilslon (see fi130ve). 
I 3 c s p i ~  the domillant concepr (ROS are procl~lced pnmrarlly wrr-11 t1ie 
reirrcrt~ducxron of trxygen hllownlg rcpcsfustlo17), several Im:est_lgntors have 083senrcd 
130S gcnern~~on d k ~ r ~ i ~ g  1sch:lernra 1141. It1 addldon, tltc facr r h ~ t  our S ~ W ~ I C S  slnolrved 
r l ~ n l  1-r.ronuHI :R ncrs prorecicc when :~pphied Ircfore ~scliaellva but nnt when apphed 
rrght bciol-c repcri~~.s~on also ind~recdy indicate poss~blc cletrlrneniall effccn of  IiOS 
clur~ng rlir euperimencnl rscl~acm~c phase. In our vaew it 1s rllerefore essenad to 
rtrrrhcr ~lcresminc to iv1ilcl-u eslerzt and at tvhich stage ROS act detrimental dus111~ 
camd~nc I I i  rnjurv in  ostler to rieli17er tlze agents In a ti~aic-sensltrve fashion. 
('ii~tlr b l i  ~/?lpkr i i r f t~~f,~ 
Sex urrul clrtzlcal sr~~clles haute ernl~larcd thc iraflue~zce of :uatioxadants alone or In varaous 
combinat~ons on 11% injury ~n laaltielicq unrlergo~ng reperfusnon therapy after myoc:trdral 
~ n f ~ ~ r c u o n .  llesplrc nzatly researclr ciiorts and a wfitlc ax-a~labnhty of anrioxadarzt agents, 

E-il(~wcver, we showed that chc ~nfarct size rs almost 4 times greater after carhac PI 
compared tcw IR (chapter 2). This means that the affected area is possibly brger  after 
PI and alterations in protleome are consequently easier to mtercept. T o  overcome this 
jxol)lern, more specific techniques, as for Instance laser: capture micro-chssection, wdl 
136: ~ C C C S S ~ T ~  tu select more spedficdlqi the affected area for analysis. This 1s mainly 
true for r k  L1R model as the infi~rcc 1s patchy ~Iistributed m the area at risk. 
In ddit ion it i, clifficult ro c16sdnpjsh bemeen detrimental effects trggered by rhe 
ischaemilc pcdocl, the sel~crfi~sion penod or  the combination lschaeda and 
reperfudon. Shclymg the changes In protexfz expression spcc~fically tngered  by JR 
wit37 different t~mc-coimbina~c-sm of lschaemia and reperhslon can reduce part of this 
proElPern. 
"The protectnz effects of rnonoMJ'R v1s18,le on  histologlcall and funct~onal Bevel were 
not clctectccl on prateorne level by using a technique of 2-DE comhined wltl~ nmss 
sp~trc~n?ecry. 
This IrnpOlies that more spec~fic tools as for example subcellular proteomics (chapcer 
I), the deteeaon aE oxidauoi~ of proteins /I $1 or of inter~naleculat psotenn disulfide 
forxnauon (191 are necessar)r LO detcrmti?e changes in the proteome due to oxidative 
stress in order to determine parts of the nlechanistn of TR injury. 
We colvclirde tliar the spcclfic al~eratinns In protern expression that take place after 
cardiac iscliaemla-reperfusion and permanent ~schacrnia may stimulate the search for 
new rcuols tu resrslve specific mecban~srns and to find spccifac targets for therapy for 
these patliolc~g~es. 
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Samenvatting 
I le t  eerste doel van &t proefschreft was om in een ~w vavr/ muizenmodel van card~ale 
ischemie-reperfus~e @K] na te gaan of de antuoxidarzte stuf 7- 
mioinul~yd~ox~rcth~lriuco~~dt (monoHER) een beschcrrnende werking heeft o p  het 
musrenhart. O m  het wc~kingsmcchanisme van monoI3ER in dit IR mode1 te 
analyseren, was het: tweede doel de vroege veranderingen LR proteirine~xpressic sn het 
rnuiïenhart te ooncIerzuelien B i j  clit model. 
1 iler in  ivo mt~izernrnodcl van carcl~ale IR IS het stud~eobject van deze chesis. Bmram 
wcrgelckcn wij in hoofdstuk 2 de strwcturelie en fiiiact,iorrele efEcct.cn van carcliale IR 
op l.iet muizen hart, met: deze gii~cl~ucccrd door perniancnte iccl-icmie PI). 
I-lct i~~erendre l  van de studnes met be~reh-k~ng ~ o t  dlt model Eiebben het accent gelegd 
op de  lwr~ctrcrmijncffcctcn van reperfusie. Door gebmik te ii-iiakcn 1.ai-i parameters als 
c ~ p ~ x r v l a k ~ e  van het infarct en ne~itrnficlinfiltratie werd de voomltgang \-an 
wccfsclcchade lscschreven binnen een ~gdsbestek van een paar uren tot een paar dagen 
na dc I I I ~ L I C C I C  van reperfuiie. De I:ingecermijneffec~en van IR-schade, in cernaen van 
wclten of maanden, w~crcicn slechts in beperla mate onelcrzoch~ rn dit rrl ,ril0 
inwiïcin~iirrdcl. IZchtcr, vorrr cxtrapolanc naar een hlliilische situra~e is het nagaan van 
de cffectcn op  lange termijn ïeer relevant, aarigezien dere kunncri verschillen van de 
rffccxen ogs liorte aermljil. 
In  hnofclcruk 2 toonden we aai1 dat de  srrucreirelc en kincuonelle effecten vair cardralc 
IR 01s Jsnge termiji-i, vcrscliillen van deze bij cardi:ile PL. Dc cuntracúhteit van het hart 
was na~~ziciilijlt z crminderd gedurende mmstens 2 weken na IR, tnaar was nlin of meer 
hersteld 8 weken na IR. Na cardnalle IR was de lalgeinenc architectuur van de wand van 
Eict linker ventrikel intact gcblcwn en was het proces van wondheling gekarakteriseerd 
cloor uitgebrcidc calcificatie, beperkte liypertrofie en beperkte dilatatie. 
I t i  liet P1 nioclcl was de  ischsri-iiiscl~e zone niet geciilcificeerd, maar 1-olledig vervangen 
dons hinduieefsel. I3ijkomencl aras liet litilier ventrikel, ten gevolge van P1, sterli 
gcdiltitecrd, Liet rcsterentle spie~t\leeifsel sterk gehypertrofieerd en het vcrlics \-:in dc 
Iliarrhiictie pernlrirxnt. 
l--lcr ~~oietltiecl brschcrinen~l effect van cxogeen roe<geclieiadc .iiiciox~dantes-i 013 carcI1:~lc. 
i.cl~d~~sicschni~iic nj~i 1 uligcbi.eid tresrudecrtl. Echtci-, m a l s  in detail bcsclireveii in 
hoofclst~i k 1 ,  blrjl,et~ clc rflctci-i \jan 11claaiidehng met :ii-irloxidantcn Ir1 tlexe rriodellenr 
~ . o n t r o v e r ~ ~ e c  en mnetcii ~ier.c vei-dcr ~~~tgc*klaard \v«rden. IrPoveircllela, tlc rnccsce var1 
tlcïc studies Iicbl~eri enkel korteteriiliji.zefEecte11 ct1 geen lai~geter~iii lneffectc~~ ~ a i i  lti? 
Lscstilideercl. 
l i l  hoc~fdsruk 3 hebhen we clc bcsclicrni~ende werking bsrn de a~atioslclariic staf 
rnomcitlllR 013 Iwt liarr, i i ~  l-iet i// /))ra niuizenn~oclel van carrliale lR ,  geio\.alueerd. Dit 
xtrl 2 \velieli s12 IR, lict cljdstip u.,rarcrp her woncthclli~gs~~roce~. \~ c~rolledigd IS. 
l i r  / i j t i  drie rctiei~cn \\.aarom we voorop sreldcn dat nnonoHlER mogelijk bcscl-iermenid 
\vei-lít rn d ~ t  cxrcliaal IR rnt~del. U c ~ c  zijn: l /  sterke rrrclicaal opva~~geiade en i j~c r -  
lsiiitlcnde elgerïsclrappei~ vat1 iuonoE IER; 2 /  de aiingetoonde l>eschertnende werking 
van monnWISR resen de cardiotosicitclr geiïid~acecrcl dons closoi-ubicnne; 3/ 218 ~ ~ i p ~ u  
;inti-r11ila111matci1ï~ effecten v~an  ti-iorioHER door ecn verrnindcnng van1 dc 
neu~rtrnficl~adhos~e. 
W*e toonden aai1 dat ir~onol-1RR biil~reniie beschcc~~~eaidc effecten licetr ~ r i  ciir { i t n  
mwzenmotiel I arn eardide IR. \Yle hebben op 2 u1,dsuppeii (24 uur en 2 \lireken *:i lR) 
aangetoond dat een behandeling met ~nonol-{ER de Rnfilniltir van neuircifielrin 
t-ermndert, dc oppemlakre van liet infarcr- reduceert er1 bijAon~cnd jrocgt voor een 
behoud van cPe cot~tracuelur er~ensclrappen van Iieï hare buj ~csweY ccin~ularir door 
dobuitamine als door voPurnebePasling. 
Voor zover we wcteri is deze sruciie de eeiste die blijvende beschcrzazcnuìe eriectcsn 
aantoorir \ia12 een flmonold in dit rnu~ze~~niodel  vrti1 carc2r:ile IR. 
Het  tijdstip, de route van toedien~izg en de tiasis var1 moncil-1LK ur:rnr i r i  cieze s t ~ ~ d ~ c  
(hoofdstuk 3) \-oor gekozen werd, zijn gebaseerd o]> ~-oorgaande sl?iidics in Je~velke 
aangetoond werd dat inonoHER een beschcamend euïcct heek In het i~-ieidel van 
dosorub~cine geinduceerde cardiotoijciteit 11, S]. In deze studies werd rnoizuf-l-lllli 
intra-perrtonenal, één uur voor doxorublcine injecue, roegediend. 
CSm de oxidatieve schade op het luart, ~reroorzaaltt door er11 c h e m o ~ h e ~ ~ p e u u ~ c l ~  
middel zoals doxorubiciae, te vertninrderen, is het loglsclu om pi~trei~teri vt~oraf ie 
behandelen met eeri antioxidanite staf als rnonol-lhiR. ILëhrcr, onl "reprsf~~sicschacTe" 
te ~e rminde~en i  is I-ret roed~etien Iran een atitloxidatlte stcaï, vi~iir de isclleiuiisclie ïasc, 
vanuit khniscla oogpunt, niet ïeYe~:int. Dorcndicn tonen recente fari~~:icokilie~~~scI '~e 
s t~~$ le s  112 munzen aan dat de m a ~ r n a l e  weefselcc~iiicentratie van tizt>tirsll-ll:lt bnliiir~ 
o n ~ d d e l l i j l i  na in~auencuze  toed ien i i~~  bereikt \vorrJt !31. 
In hoofdstuk 4 oi~de~zochten. we: daaronn of inonuIlER tevens effectief w:itiireet 
her intraveneus, vijf rminuten vóór reperfusie, locgeelieild \vercl. 'ioedicizlilg vati 
rncmnoHRR beïnvloedde de  iinfiltratie vali neutrcafieleii in hel Iiart.veeilscl, nijcl-1 luiud het 
een beschermend effect o p  de cardiale corztraculireic, 24 uur iia reperfusie. 
MonoHER heefi. cllus een besclzermendc werkuilg in her /n r>i/v iiiiuizei~model van 
cardlale 1R \va.nnecr hei incrapeirmtoneaal, &én uur vOór ischemic toeKed~eiid ~ioiclt ,  
 ina aar nleil viianneer het intraxPeneur, vii f rrilnutcn vzicir i-epcrfusme tnegc-dlencl a.orclt. 
Deze discrepantie dn resultatesa (tussen h~30fdstiik 3 e11 4) toonf íaarr clar hcl rujdstip van 
rncrnoHTSK tcledlening zeer cruci;r:rI is crin eeii ïijn eicscIicr1~1ci1c2 c ï f ~ ~ . (  !L: I . ( ~ R ~ ~ s ( I ~ ~ I I .  
hIogc2tjke ~irrklnrin~en voor her ontbi-elcerï x v n m  ccn hrir.iacocl~1~;1111~~~11 cfiCct V:I~I 
monol.-IER rir deze l~a ts te  studje (l~~olc-lsiuli 4) /fin: l /  de rnogcllll<e Ircl--rsrl;ing r o l  cle 
opnai~ic \fan inoriotlBR cloor het Pl:~rr\veci.sel in 11cl ïiioclcl \.:ai? earclinlc 131: 2/ tic: 
noodzaak voor de v o r ~ ~ ~ ~ t z g  xJ:err actieve ri-ictabolierciu u.:~i.i iinoiaot Il:H; c.n 3 /  de limas 
dat 13escluerlmende effecten, cncr;.ijc\s tilirect of arrder~lltlc inclircct vlia .~nlr~~xi~l:irrle 
effeccell, te wilteil zijn aan een .li,risscI~crliing va11 riltriioI~l:R nrct \13cciiiekc 
signaaJitransduct~ecascaclec gcdurentlc dc ~ricrrotlc vnn c IJcze 
s I c w a a ~ t r r r n s ~ ~ ~ ~ e C ' 1 5 ~ : ~ ~ e ~  zourlen Iltui~nen geassociecrci ï i jn  :r%n tic: E~cscl~crinciztlce 
werking I~RPI rnont~HF~Ti. 
Aarlgezierz cgnrioitransducnecasmdes opgc-boii\z.d 71 j i i  w i t  protciiien IS I~ei  esscniiecl 
<>na, ten ejncle dezc bul-><itI~esc te ven fieren, t~erm1dcri1.i1gciz i t i  p i -~~ei r~cc .xpr~\s le  of 
posc-rranslatlonele rnodificaues van prntcilncn te E~ëstudcrcrr. 
D;tarorn werden 2 meksen 'prtstcoïnics' studies uitgevoerd d.m..ir. de teclinlek van 2-D 
glclecrroforesc geeamluincl-rd met massaspc-ctroimetne (hls) eocjr de hrakterisaue 
van de proreinm. 
kange~it ln  we in eerste mstantrc geínteresseerd waren in de oorzaak van de 
bcscherrneiidc werking van rnonoEIl-ZR, bestudeerden we vroege (na 210 ii~ii~uten) 
vieranderingen in proteïnetxpressie. Bnjkornend waren we geïnteresseerd rn her 
icUentificeren van potenttcel onbekenclr: 'prottin targets' &e een Invlocd hebben irr dc 
vrocge Fase níi hel oarstliain vasa een harunfarct. Voorgaande studies van andere 
labora~ona toontlen aai1 dat cicïe techniek in staar rs om vroege veranderingen an liet 
proteao~m, ~ïncluceterd door cardiale SR, te detecteren 14-61. 
En hoofdstuk 5 vergeleken we de  veranderingen in protcirredensireit In de 'area at nsk' 
van het rnu~zcnliart l ~ i i  171 riva PI eir 113. \Ve analyseerden zowel cytosolzsche als 
m e n ~ l ~ l . : ~ , ~ ~ ~ i j ' a c ~ ~ e a  en vo~lden een rotaal van 32 proteinespots (uit ongeveer GO0 
"natchcel' spots) dic differentieel tot cxpreasle kwarrren. 
,Flikt cUeze iecliiiick waren wc in staat o m  20 protemnespots te bepalen die enkel ria PP 
wcranclerdcn nn dci~sitert, 4 proidnespots dic cizkel na IR veranderden in densiteit en 
tenslotte H prnteiriesl,ots die gcn~censchappclljli in bede  modellen veranderden 111 
clensiieir. D e  resulutten van deze studie 7iln daarom een 12asis voor verdere studies m 
dewclke cle spccifiekr functionele tclevantie van dcyc proteïnen In modellen van 
I~rartinfat-ct onderzocht kureiien wardeii. 
Cic geiclen~~rfìccerde proteinen (cloor MS) klisinen worden geclasslfieecrd In zeven 
funcrioizelc p;loepen, met narrie: i /  anuco~~tfwlante lirciteitren (rhnnexin A3&A5), 2 /  
strilicturcle proteïncrz (carcliac trc~ponin "I', a-trnpornyosin and a-myosiri heavy chiun), 
3/ inflamrziatoir-gere1:xteerde pr-otcirieir (serum ariij.loid L'-component precursor), 4: 
cranscrip~lc- cil trans1:ir~c- gerelateerde protcïnlen (Prohlbitm and F-Iistidiiie T'riad 
Nucleotide Uinding Prorein 1, 1 lrcrcrolgeneous Nuclcar Riboiiucleoprcl.ccin K), 5/ l-iear 
slqock proteinen (Heat SIiocli Protein 20 ei1 Heat Shock Prntein 2 7 ,  6J nzetabolisme- 
gercliltcerdr prciteineii (Adcnylate Kinase 1, Pyruvate 13r'hydrogenasc E? Connponient 
Ueta Suliiunlt, Q3arecliol-O-hleh).1tr~nsferasc) en 7 J  overlgc (diral specificnrz 
pl~or;pû1:1~;7se, inrilar to Zn-~Pcohol cleh!~drcjgcnase). 
!7~1l  c~pnicrlililllke 1>cvin~!lilig was d e  tr<rilslocaae .i an anrrcxii~cs (A3 en AS) !,ar1 liet 
cytohol#~cI~e n a ~ r  Izet tmesnbranaire cclco~np:irtii~aefit~ uldei~s ciirciiale IK .  Een 
1i~eviiniling tlic tevcris I.~evcstigcl wei-t1 d.11i.v. '\Western bl~tting' .  Bler fele clat dit 
fciitrtmecn eiil~c-l iaprrcedt iia re1~eriFlisic cri nicr 112 peri-ni~nente nsclieizuic s~i~ggereet-t ccrr 
spccficli rncch:inisrrnc dat de  trsilrzslocarir van :rizriexirrcs Pnduccerr gedurende 
rclxrl~isii". 1Jer.c be.r~incI~nge~i zrjt-i ccn bijkomende srlnz?u'l;i~is T-oor z crdcse studies n l i  
ce lde  tor railireillnes eii de vroege diagnose v:rn re~~erfu~escl-iacle met betielikiirg tot 
\~oorga;~ntIe st~itiic5 in ons Iali>ornl.cili-iuru>sat~~r~~~ii~ 171. 
\'icr. proteincti u.iircn op iinecrtlerc spotlocat~es lcranderd In espressienjz~eau, 
gdiai-nhici.iseerd cioc~r ccir verschil in  isoclectrisclr plint. In liet geval van tropnninc T 
cri I-IS13-21)i waircn t l c x  veranderingen ook afliankclljk  aia a. het model. Bijkorncnd, kkn 
~ V A E  YOCIS dc prrircrnlen adciiu.laite kinacc 1, rroponurae T c11 HSP-20 w:is unilek 
:ranu.e-1% in dc l l i  en lof  rlc PI $roep en nlct in de ïespeci~cvelijke sham groeyen. 
\ joortgc~et oridcrztack. is iiciclig I ooi- Ilei bclgalen van pathologie gerelateerde post- 
tr:inslLiliritrclc n~oclificiitics. 
Snrnrrn\~nol~ng * 
Een toiaal van 12 protelnci,pors veranderde i r ~  expncsurn7i~rx~ 112 c~-ardicll~ 1R 
@ooMstuk 6). Tien van deze proseYnespota konden gekaralirenscel-c1 \vosde11 riwr MS. 
Deze waren: Heat Shock Proteïrie 20 ei1 Heat SE7nck Pror-lt-ie 27, Hctero.qnc.ous 
NucPeai: Rrbonucleoprotein K, Pjruvate Dehy~lro-nase E l - p ,  Arrriexlne A3 (op 2 
spadwcaues), l lual Specificrty Phospluatase-3, C:,ziechnl-iC)-b\lcrI2yltr:1rrsfirnse, :ziiicl 
Acienylate Kitlsse 1 (op 2 spodocaties). 
I le intraperitoneale toediening v:in u~i~n0Hli13~ één uur \ijC~r ischemie, iiad geera 
invloed op l-iet profiel van pït~teïiie~s~~ressic gcrcla~eerd aan cardislc 11%. Dlc betelient 
dat de beschermende effecren vm insnol-11% op lailagc-rexmijn, dne aaligrioond 
werden op fiistologisct~ en f-ilnruotleel niveau, niet gexssocicrerei \v:ircn rrteir 
deitecteet-bare vroege .ireran~leringrr.ii In het proreoom, nagegaan mcr 1-13 gel 
electïoforese. hlsgelijke verklaringen voor C I C  discscpnnric in resultatei1 tiisseri beide 
stuclirs in? l-ioofdstuk 3 en 6 zijn: 1 $ rnoi~aHI~R I-ieeft geen ~n\.loed op tie 
vcraridcringen in proteïrieExpressie na cai.dr:ile IR, S J  Izet gel.tn7rn-i tijdsrip is niet 
relevzint voor het detecteren vati \ieranderingen in llcr proreooizi ì,emc~rz:lalit cloor 
rnonolil;R; 3," de techiuek die we ge\3riilkr hebbcn was Iliet ~ r r  s t m l  airn ver;tndeiiiigcrr, 
in Iret proteoom, specifiek verooi-aaakt door iinonoh IER, t~si? te tonen. 
We conclwdcreri. clat de specjfieke veraazdcringen ii-i proieinc~uprcsssne d ~ e  
plaatswndlera na cardi~le iscl-ietminic-reperfuslc cn pertl1anicnce Is~:lic~-izrc CIC xoekt~cl~t.  
stimuleren rraar mddcllen voor liet on~ru6e'elcii. van specifieke mech:~nismeiz en het 
vinden van specifieke 'targets' dle als theraiple kilinilcti gclrru~kt wordet-i. 
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